DNA repair process key to memory formation, study finds

Lykos will be culling 75% of its workforce as it continues to work on the MDMA therapy. Image credit: Getty Images / mathisworks Lykos Therapeutics

Beyond gMG, efgartigimod SC is under evaluation for the treatment of additional autoimmune disorders. Credit: Gorodenkoff/Shutterstock. China’s National Medical Products Administration (NMPA) has approved for

Mer­ck closed its $10.8 bil­lion ac­qui­si­tion of Prometheus Bio­sciences, set­ting the stage for the drug­mak­er’s pur­suit of an im­munol­o­gy block­buster. In a news re­lease on